Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2025 (69)
  • 2024 (90)
  • 2023 (75)
  • 2022 (71)
  • 2021 (56)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4103)
  • Synthetic drugs (1097)
  • Guns/Weapons (1009)
  • OCDETF/Task Force (817)
  • Fake Pills (669)
  • Arrests/Convictions - Major (623)
  • Guilty Plea (540)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (370)
  • Overdose (324)
  • Major Law Enforcement Operation (274)
  • Diversion Division (250)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Money Laundering (207)
  • Gangs (199)
  • Outreach/Drug Prevention (185)
  • One Pill Can Kill (113)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Counterfeit Pills (25)
  • Fentanyl Free America (24)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Other (11)
  • Campaigns (10)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (226)
  • Fentanyl Awareness (158)

Drug Name

  • Fentanyl (108)
  • Opioids (50)
  • Oxycodone (48)
  • Methamphetamine (17)
  • Synthetic Opioids (17)
  • Hydromorphone (14)
  • Cocaine (10)
  • Morphine (8)
  • Benzodiazepines (7)
  • Heroin (7)
  • Ketamine (3)
  • Marijuana (Cannabis) (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Xylazine (1)

Field Division

  • Washington, DC (43)
  • St. Louis (39)
  • Houston (35)
  • New York (27)
  • Miami (22)
  • Omaha (22)
  • Chicago (20)
  • Louisville (19)
  • Atlanta (18)
  • Sede (18)
  • Rocky Mountain (15)
  • El Paso (14)
  • Los Angeles (14)
  • New Jersey (14)
  • Seattle (14)
  • New Orleans (11)
  • San Francisco (9)
  • Dallas (8)
  • New England (7)
  • Phoenix (7)
  • San Diego (6)
  • Philadelphia (1)
Clear All Results
384 Results - Showing 191 to 200
PRESS RELEASE

DEA Washington Division Encourages Back to School Drug Awareness and Education

WASHINGTON, D.C. – As students return to school across the DMV, the DEA's Washington Division urges families to have open conversations about the dangers of drug experimentation and use. “Our citizens, especially our youth, are being exposed to an illicit drug supply that is more dangerous than ever before, making...
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day with Extended Hours for the Faces of Fentanyl Exhibit

WASHINGTON – The Drug Enforcement Administration recognizes National Fentanyl Prevention and Awareness Day by joining the dedicated voices who continue to raise awareness in an effort to prevent the fentanyl poisonings devastating families across the country. On Monday, August 21 the DEA Museum will open with extended hours from 6...
PRESS RELEASE

DEA Encourages Back to School Drug Awareness and Education Among Family and Friends

OMAHA, Neb. – Students across the Midwest are returning to school and the Drug Enforcement Administration (DEA) Omaha Division is reminding families to make time for honest discussions about the dangers associated with the experimentation and use of drugs. “Never underestimate the impact that one conversation can have,” DEA Omaha...
PRESS RELEASE

Missouri Woman Admits Fraudulently Obtaining Pain Pills Meant for Animals

ST. LOUIS – A woman who worked for a pet food company in Montgomery City, Missouri, admitted fraudulently obtaining pain pills meant for animals on Friday. Mackenzie Noel Deeker, 39, of Montgomery County, Missouri, pleaded guilty in front of U.S. District Judge Sarah E. Pitlyk to a felony count of...
PRESS RELEASE

Physician Assistant at Chicago Medical Practice Charged with Fraudulently Writing Opioid Prescriptions

CHICAGO — Sheila G. Lyons, Special Agent in Charge of U.S. Drug Enforcement Administration Chicago Field Division, and Acting U.S. Attorney Morris Pasqual for the Northern District of Illinois announced that a physician assistant who formerly worked at a Chicago medical practice has been charged in federal court with fraudulently...
PRESS RELEASE

Toms River Woman Charged with Unauthorized Practice of Medicine, Forgery, Health Care Claims Fraud, and Distribution of a Controlled Dangerous Substance

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and Ocean County Prosecutor Bradley D. Billhimer announced that on July 25, 2023, Maria F. Macburnie, aka Marife L. Macburnie, 62, of Toms River, was charged with Practicing Medicine by an Unlicensed...
PRESS RELEASE

Suburban Chicago Physician Sentenced to Federal Prison for Prescribing Opioids Without a Medical Exam

CHICAGO — Sheila G. Lyons, Special Agent in Charge of U.S. Drug Enforcement Administration Chicago Field Division, and Acting U.S. Attorney Morris Pasqual for the Northern District of Illinois announced that a suburban Chicago physician has been sentenced to a federal prison term for prescribing opioids to patients without a...
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
PRESS RELEASE

DEA Albuquerque Office Partners with Bernalillo County to Host Free Training for Employers

Albuquerque, N.M. – As part of Operation Engage, DEA Albuquerque has partnered with Bernalillo County to host a free CADCA training for employers seeking to address problematic substance use and misuse in the workplace. The 90-minute training will discuss how problematic substance use impacts businesses and their employees, how to...
PRESS RELEASE

Fourth Circuit Upholds Former Tabor City Doctor’s Conviction for Operating a Pill Mill

NEW BERN, N.C. – A three-judge panel from the Fourth Circuit Court of Appeals issued a unanimous, published opinion affirming former physician Jong Whan Kim’s conviction and sentence for operating a pill mill in Tabor City. The Fourth Circuit’s decision was the first published opinion by the Court upholding a...

Paginación

  • Primera página «
  • Anterior
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Current page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster